Who starts antiretroviral therapy in Durban, South Africa?. not everyone who should

AIDS

Volumn 24, Issue SUPPL. 1, 2010, Pages

  Bassett, Ingrid V ^a,b   Regan, Susan ^b   Chetty, Senica ^c   Giddy, Janet ^c   Uhler, Lauren M ^b   Holst, Helga ^c   Ross, Douglas ^d   Katz, Jeffrey N ^e,f   Walensky, Rochelle P ^a,b,g   Freedberg, Kenneth A ^a,b,f,g   Losina, Elena ^b,e,f,h  

^a Division of Infectious Diseases   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCCORD HOSPITAL   (South Africa)

^d St Mary's Hospital   (South Africa)

^e Division of Rheumatology   (United States)

^f Department of Orthopedic Surgery ^*  (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIV testing; HIV 1; Linkage to care; Loss to care; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOUTH AFRICA;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; DRUG ADMINISTRATION ROUTES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL RECORD LINKAGE; SOUTH AFRICA;

EID: 74249123824     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000366081.91192.1c     Document Type: Article

References (27)

1. World Health Organization, UNAIDS. Epidemiological Country Profile on HIV and AIDS: South Africa 2008. Available at: http:// www.who.int/globalatlas/ predefinedReports/EFS2008/short/ EFSCountryProfiles2008-ZA.pdf. Accessed: 3 August 2009.
2. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. Available at: http://www.who.int/hiv/pub/towards- universal-access-report-2008.pdf. Accessed: 3 August 2009.
3. United States President's Emergency Plan for AIDS Relief. Accountability: Report on PEPFAR partnerships for prevention, treatment and care. Available at: http://www.pepfar.gov/press/ fifth-annual-report/113725.htm. Accessed: 3 August 2009.
4. The Global Fund ARV fact sheet. Available at: http://www.the-globalfund. org/content/pressreleases/pr-090708-Factsheet.pdf. Accessed 28 October 2009.
5. EU at United Nations, Partnership in Action. Commission approves substantial programme to strenghten health care and fight HIV/AIDS in South Africa. Available at: http://www.eu-un.europa.eu/articles/en/article-1171-en. htm. Accessed: 28 October 2009.
6. UNAIDS. Country situation: South Africa, July 2008. Available at: http://data.unaids.org/pub/FactSheet/2008/sa08-soa-en.pdf. Accessed: 28 October 2009.
7. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
8. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antire-troviral therapy programmes in lower-income countries. Bull WHO 2008; 86:559-567.
9. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22:1897-1908.
10. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19:2141-2148.
11. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4:e298.
12. Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med 2008; 168:86-93.
13. Republic of South Africa Department of Health. National HIV and syphilis antenatal seroprevalence survey in South Africa: 2006. Available at: http://www.doh.gov.za/docs/index.html. Accessed: 3 August 2009.
14. Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, et al. Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr 2007; 46:181-186.
15. South African Government Information. Operational plan for comprehensive HIV and AIDS care, management and treatment for South Africa, 2003. Available at: http://www.info.gov.za/ issues/hiv/careplan.htm. Accessed: 3 August 2009.
16. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 2009; 51:135-139.
17. Bekker LG, Myer L, Orrell C, LawnS, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006; 96:315-320.
18. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, et al. The "ART" of linkage: early loss to follow up (LTFU) after HIV diagnosis at two PEPFAR sites in Durban, South Africa. In: XVIIth International AIDS Society Meeting. Mexico City, 3-8 August 2008 [poster TUPE0345].
19. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr 2009; 52:397-405.
20. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18:887-895.
21. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R. Determinants of mortality and nondeath losses from an anti-retroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006; 43:770-776.
22. Mills EJ, Ford N, Mugyenyi P. Expanding HIV care in Africa: making men matter. Lancet 2009; 374:275-276.
23. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health 2008; 17:47-55.
24. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, et al. Gender distribution of adult patients onhighly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007; 7:63-70.
25. Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretro-viral medication adherence. AIDS Behav 2006; 10:483-493.
26. Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav 2006; 10:263-272.
27. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4:e5790.